Virtmed gains $43 million in second round of fundingVirtmed has secured more than $43 million from investors in its second round of funding. Among the investors are eHealth Technology Fund, New Enterprise Associates, Frazier & Co., and the
Virtmed has secured more than $43 million from investors in its second round of funding. Among the investors are eHealth Technology Fund, New Enterprise Associates, Frazier & Co., and the venture arm of 3Com. Virtmed is a three-year-old Cambridge, MA, firm that is banking on the integration of wireless devices, Internet technologies, and existing healthcare information systems to give doctors and nurses access to patient and other data at the point of care.
Virtmeds primary product is a thin-client server designed to sit on-site and direct data between existing databases and handheld devices. The firm has also developed online reporting functions to allow users to update patient charts remotely.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.